Analyst Ratings for AstraZeneca PLC ADR (AZN)

Updated: 2017-07-26

An average rating of Overweight has been given to AstraZeneca PLC ADR (NYSE:AZN) by analysts covering the stock. A consensus rating of Overweight was previously issued for AZN last month.

18 analysts declared AZN a buy, 2 gave an overweight rating, 14 gave a hold rating, 1 gave an underweight rating, and 4 gave a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has decreased by 2. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

AZN was given price targets by several analysts. The most optimistic analyst gave a price target of 51.55, implying potential capital gains of 52.74 percent. The most pessimistic price target was 25, implying a possible loss of -25.93 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of -5.73 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -4.6 percent. Over the past 30 days, FY earnings estimates have also changed downwards by -0.54 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 1.1 percent.

People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 0 analysts increased their quarterly estimates, while 2 analysts made negative revisions. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, while 3 analysts decreased their estimates.

The growth rate of AZN's earnings is estimated by analysts to be 50.63 percent. The PEG ratio of a stock is another value frequently studied by investors. A lower PEG ratio is favorable, because people typically see that as an indicator of higher growth relative to stock price. Wall Street investors typically prefer a PEG ratio to be smaller than 1, though it could be better to see where the ratio stands relative to peers in the industry. The PEG ratio of AZN is 0.55.

AZN has a 52-week high of 35.60 and a 52-week low of 25.55. The current market price is above the trailing year's low by 32.09 percent, and 5.2 percent lower than its 52-week high. AZN has a P/E ratio of 27.61. Investors typically compare the P/E ratio to a company's peers in the industry. The AZN value stock report compares AZN to some of its peers using value stock charts. The stock has a market capitalization of $84.02 billion. AZN is estimated to release their earnings results for the quarter on 0000-00-00, days from today.